In total, the SDH-germline mutation can be driver mutations of Paraganglioma, Pheochromocytoma, Gastrointestinal stromal tumors, Renal Cell carcinomas and other endocrine-related tumors. This evidence concerns the gene SDHB and paraganglioma.